Nathalie Maubon CEO of HCS Pharma will be alongside with our longtime partner Molecular Devices in Taiwan on the 5th of October. This event as always is designed by Molecular Devices to inspire, educate, and connect scientists, researchers, and professionals in the field. We thank our partner Molecular Devices for Read more…
We are really pleased to announce that we will be present in BioAsia-Taiwan and present our breakthrough technology BIOMIMESYS alongside our partners Molecular Devices (USA) and LumiSTAR Biotechnology (TW). We are 3 companies in 3 different continents unifying their strenghs to develop the best strategy to find new and more Read more…
During the Healthcare Expo organized that take place in Taïwan between the 30th of November and the 3rd of December, our partner Tokyo Future Style Taiwan had a booth and presented BIOMIMESYS® technology. Dr Dar-Bin Shieh stayed a lot of time with our partner to discuss with Joseph and his Read more…
One week later after our business trip in Asia, we are lucky to welcome Pr Dar Bin Shieh from National Cheng Kung University (Taiwan) in Lille on the 16th of November. In the morning, we have been invited in OncoLille, we have presented all our work in oncology field with Read more…
In order to make known BIOMIMESYS technology, Grégory and Nathalie were in Asia in October during one month. The first step was in Japan. We have worked with our partners from AS ONE and JVC Kenwood. We had the opportunity to visit them in AS ONE office in order to Read more…
During the last BIO Asia-Taiwan event HCS Pharma was awarded by the National Health Research Institute (NHRI) as a key company (關鍵新創) in the “Partnering and Medical Innovation” category (攜手同行暨創醫獎) for the BIOMIMESYS® technology. BIOMIMESYS® was recognized as a groundbreaking technology, allowing to reproduce any type of healthy or cancerous Read more…
We are very happy to be present at BIO Asia-Taiwan this week as a member of the National Health Research Institutes (NHRI) Technology Transfer & Incubation Center (TTIC). You can find us on the NHRI’s booth, 4th floor R332. We will present our products BIOMIMESYS® and our last developments. If Read more…
Today is the opening of the virtual part of 2021 BIO-Asia Taiwan and we are happy to welcome you on our booth (R332) to present our latest innovations with BIOMIMESYS® for liver organoids. This event is organized by Taiwan Bio Industry Organization and Chan Chao International Co. It gathers over Read more…
We are really pleased to announce that we have officially created a representative office in Taïwan (company 仿生培養技術中心 ID number 90729614) which is directed by our partner, Joseph Chou 周肇隆 ジョーゼフ・チョウ, member of our advisory board. Thanks to Joseph and Professor Szecheng J. Lo, member of our scientific advisory board, all Read more…
We are really proud to work on a real partnership with the team of Tokyo Future Style (TFS) Taïwan for almost a year now. Joseph Chou, member of our business advisory board and Pr John Lo, member of our scientific advisory board, have fully understood the value of BIOMIMESYS® our Read more…
We were in Taiwan few weeks ago, invited by our partner Molecular Devices to talk about our skills in 3D cell culture, with our unique groundbreaking technology BIOMIMESYS® and our services for in vitro screening from cell assay development to picture and data analysis. It was also a perfect opportunity Read more…
We are very happy to be invited by our partner Molecular Devices at the user meeting of Taipei (Taiwan) and Beijing (China) this month to talk about phenotypic screening and 3D cell culture. We will be also in Japan to meet our local distributors and customers. On October 17, we Read more…